Literature DB >> 29356821

The Federal Right to Try Act of 2017-A Wrong Turn for Access to Investigational Drugs and the Path Forward.

Alison Bateman-House1, Christopher T Robertson2,3.   

Abstract

Mesh：

Substances：

Year:  2018        PMID： 29356821     DOI： 10.1001/jamainternmed.2017.8167

Source DB:  PubMed          Journal:  JAMA Intern Med        ISSN： 2168-6106            Impact factor:   21.873


× No keyword cloud information.
  12 in total

Review 1.  Ethics codes and use of new and innovative drugs.

Authors:  Jan Borysowski; Hans-Jörg Ehni; Andrzej Górski
Journal:  Br J Clin Pharmacol       Date:  2019-01-04       Impact factor: 4.335

Review 2.  Concise Review: A Comprehensive Analysis of Reported Adverse Events in Patients Receiving Unproven Stem Cell-Based Interventions.

Authors:  Gerhard Bauer; Magdi Elsallab; Mohamed Abou-El-Enein
Journal:  Stem Cells Transl Med       Date:  2018-07-31       Impact factor: 6.940

3.  Right to Try Requests and Oncologists' Gatekeeping Obligations.

Authors:  Holly Fernandez Lynch; Ameet Sarpatwari; Robert H Vonderheide; Patricia J Zettler
Journal:  J Clin Oncol       Date:  2019-10-15       Impact factor: 44.544

4.  The Critical Role of Medical Institutions in Expanding Access to Investigational Interventions.

Authors:  Kayte Spector-Bagdady; Kevin J Weatherwax; Misty Gravelin; Andrew G Shuman
Journal:  Hastings Cent Rep       Date:  2019-03       Impact factor: 2.683

5.  RxLegal: A Rapid Review of Right-To-Try.

Authors:  Michael Gabay
Journal:  Hosp Pharm       Date:  2018-06-20

6.  Expanded Access and Right To Try Requests: The Community Oncologist's Experience.

Authors:  Marjorie E Zettler; Yolaine Jeune-Smith; Bruce A Feinberg; Eli G Phillips; Ajeet Gajra
Journal:  JCO Oncol Pract       Date:  2021-04-22

7.  On Patient Safety: A Right to Try, Not Exploit.

Authors:  James Rickert
Journal:  Clin Orthop Relat Res       Date:  2021-07-01       Impact factor: 4.755

8.  "I Think It's Been Met With a Shrug:" Oncologists' Views Toward and Experiences With Right-to-Try.

Authors:  Cambray Smith; Jeremiah Stout; Alex A Adjei; Jan Buckner; Mark Wentworth; Jon Tilburt; Zubin Master
Journal:  J Natl Cancer Inst       Date:  2021-06-01       Impact factor: 13.506

9.  Expanded Access as a source of real-world data: An overview of FDA and EMA approvals.

Authors:  Tobias B Polak; Joost van Rosmalen; Carin A Uyl-de Groot
Journal:  Br J Clin Pharmacol       Date:  2020-04-07       Impact factor: 4.335

10.  Right now, in the right way: U. S. Food and Drug Administration's expanded access program and patient rights.

Authors:  M E Blair Holbein; Kevin J Weatherwax; Misty Gravelin; Raymond Hutchinson; George A Mashour
Journal:  J Clin Transl Sci       Date:  2018-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.